ABSTRACT
We investigated the actual factor determining the softening effect of a fabric softener. The adsorption area of the softener on model cotton cloths and yarns was identified using bromophenol blue. There was almost no softener at the cross-points of the yarns in the cloth samples or in the inner part of the yarns. The softening performance was better when there was less softener at the cross-points of the yarns than when the yarns were evenly covered by the softener. Thus we conclude that the presence of softener at the cross-points of yarns is not a vital factor in the softening effect. In addition, more softener was found on the outer part of the yarn than the inner part, indicating gradation in the adsorption pattern of the softener. Thus, we propose that more softener is adsorbed on the exposed part of the yarn in a cloth, and the formation of a hydrogen-bonding network containing bound water is inhibited, thus softening the outer part of the yarn. However, the presence of a small amount of softener in the inner part of the yarn preserves the hydrogen-bonding network. Favorable elasticity, or bounce, of the yarns and cloth is realized when an appropriate amount of softener is used. Excess softener would reach the inner part of the yarn, reducing the diameter of the core part of the yarn, making the cloth appear wilted.
ABSTRACT
Most softening agents, such as rinse cycle fabric softeners, used by consumers at home contain cationic surfactants that have two long alkyl chains as their main component. The softening mechanism on fibers, especially cotton, has not yet been scientifically established, despite the market prevalence of fabric softeners for decades. One explanation for the softening effect is that the friction between fibers is reduced. According to this explanation, the fiber surfaces are coated by layers of alkyl chains. Because of the low coefficient of friction between alkyl chain layers of low surface energy, the fibers easily slide against one another yielding softer cotton clothing. However, no direct scientific evidence exists to prove the validity of this explanation. The softening mechanism of cotton yarn is discussed in this paper. Bending force values of cotton yarn treated with several concentrations of softener are measured by bend testing, and cotton and polyester yarns are compared. Results indicate that increases in cotton yarn hardness after natural drying are caused by cross-linking among inner fibers aided by bound water. This type of bound water has been known to exist even after 2 days of drying at 25 °C and 60 % relative humidity. Yarn dried in vacuo is soft, similar to that treated with softener. Thus, some of the softening effect caused by fabric softeners on cotton can be attributed to the prevention of cross-linking by bound water between cotton fibers.
ABSTRACT
1. To investigate the pharmacological effects of T-1095, this novel derivative of phlorizin was administered to GK rats for 8 weeks. T-1095 treatment significantly lowered plasma glucose and glycosylated haemoglobin (HbA1c) levels, but did not significantly affect bodyweight. 2. T-1095 treatment did not affect 3.3 mmol/L glucose-induced insulin secretion in the isolated perfused pancreas of GK rats. 3. The peak insulin release in T-1095-treated GK rats was significantly higher during the first phase than in untreated GK rats (3-4 min after beginning 16.7 mmol/L glucose perfusion). The total amount of insulin secreted during the first phase in T-1095-treated GK rats was significantly higher than in untreated GK rats (35.3 +/- 1.4 vs. 27.3 +/- 2.5 ng in T-1095-treated compared with untreated rats, respectively). 4. During the second phase, insulin release in T-1095-treated GK rats was somewhat higher than in untreated GK rats (7-30 min after beginning 16.7 mmol/L glucose perfusion). The total amount of insulin secreted during the second phase in T-1095-treated GK rats was significantly higher than in untreated GK rats (88.2 +/- 6.1 vs. 68.1 +/- 5.7 ng, respectively). 5. The total amount of insulin secreted during perfusion in T-1095-treated GK rats was significantly higher than in untreated GK rats (123.5 +/- 7.3 vs. 95.4 +/- 7.7 ng, respectively). 6. These data show that the metabolic indices, plasma glucose and HbA1c levels and insulin secretion are significantly improved by T-1095 treatment in GK rats, which are spontaneously diabetic rats, suggesting its usefulness as a novel oral therapeutic antidiabetic agent.
